Norihiro Takenaga

Synthesis, Structure−Activity Relationships, and Biological Profiles of a Quinazolinone Class of Histamine H₃Receptor Inverse Agonists

Tsuyoshi Nagase, Takashi Mizutani, Shiho Ishikawa et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

Absorption of a novel prodrug of L-dopa, L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine (NB-355). In vitro and in situ studies.

Akihiro Hisaka, S. Kasamatsu, Norihiro Takenaga et al. · Drug Metabolism and Disposition · 1990 · 52 citations

Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18

Terence G. Hamill, Nagaaki Sato, Makoto Jitsuoka et al. · Synapse · 2009 · 44 citations

Mechanism of the anti‐obesity effects induced by a novel Melanin‐concentrating hormone 1‐receptor antagonist in mice

Masahiko Ito, Akane Ishihara, Akira Gomori et al. · British Journal of Pharmacology · 2009 · 38 citations · Full text

Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists

Takashi Mizutani, Tsuyoshi Nagase, Sayaka Ito et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 31 citations · Full text

Medicinal Chemistry, Derivatives, Biochemistry +9